Erratum: Gallbladder cancer during pregnancy treated with surgery and adjuvant gemcitabine: A case report and review of the literature

Erratum: Gallbladder cancer during pregnancy treated with surgery and adjuvant gemcitabine: A case report and review of the literature

Bibliographic Details
Main Author:	Frontiers Production Office
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Oncology
Subjects:	gallbladder cancer chemotherapy pregnancy gemcitabin biliary tract cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1175336/full

Similar Items

Gallbladder cancer during pregnancy treated with surgery and adjuvant gemcitabine: A case report and review of the literature
by: A. Diciolla, et al.
Published: (2022-10-01)

Establishment of a Pretreatment Nomogram to Predict the 6-Month Mortality Rate of Patients with Advanced Biliary Tract Cancers Undergoing Gemcitabine-Based Chemotherapy
by: Chiao-En Wu, et al.
Published: (2021-06-01)

Krukenberg Tumor Related to Gallbladder Cancer in a Young Woman: A Case Report and Review of the Literature
by: Giulia Grizzi, et al.
Published: (2023-06-01)

The Many Hidden Faces of Gallbladder Carcinoma on CT and MRI Imaging—From A to Z
by: Damaris Neculoiu, et al.
Published: (2024-02-01)

Targeting P53 as a Future Strategy to Overcome Gemcitabine Resistance in Biliary Tract Cancers
by: Chiao-En Wu, et al.
Published: (2020-10-01)

A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study
by: Monica Niger, et al.
Published: (2024-04-01)

Erratum: Preoperative immunological plasma markers TRAIL, CSF1, and TIE2 predict survival after resection for biliary tract cancer
by: Frontiers Production Office
Published: (2023-09-01)

Impact of conversion surgery after chemotherapy in patients with initially unresectable and recurrent biliary tract cancer
by: Ikuo Nakamura, et al.
Published: (2023-11-01)

RRM1 Expression as a Prognostic Biomarker for Unresectable or Recurrent Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin
by: Jung Won Chun, et al.
Published: (2021-10-01)

ATM Inhibitor Suppresses Gemcitabine-Resistant BTC Growth in a Polymerase θ Deficiency-Dependent Manner
by: Yi-Ru Pan, et al.
Published: (2020-11-01)

Real-World Evidence on Palliative Gemcitabine and Oxaliplatin (GemOx) Combination Chemotherapy in Advanced Biliary Tract Cancer
by: Hanna Lagenfelt, et al.
Published: (2021-07-01)

Current progress in perioperative chemotherapy for biliary tract cancer
by: Tatsuya Ioka, et al.
Published: (2023-07-01)

The Role of Adjuvant Single Postoperative Instillation of Gemcitabine for Non-Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
by: Georgios Koimtzis, et al.
Published: (2022-05-01)

A Population-Based Retrospective Study of Biliary Tract Cancers in Alberta, Canada
by: Carissa Beaulieu, et al.
Published: (2021-01-01)

Gallbladder cancer mimicking perihilar cholangiocarcinoma—considerable rate of postoperative reclassification with implications for prognosis
by: Lynn E. Nooijen, et al.
Published: (2023-09-01)

Synergistic and Pharmacotherapeutic Effects of Gemcitabine and Cisplatin Combined Administration on Biliary Tract Cancer Cell Lines
by: Yasunari Sakamoto, et al.
Published: (2019-09-01)

Case report: From palliative to potentially curative – the advent of immunotherapy providing hope to advanced gallbladder adenocarcinoma
by: Eugene Kwong Fei Leong, et al.
Published: (2024-02-01)

Approach to Biliary Malignancies
by: Louise Lee, et al.
Published: (2023-09-01)

Global, regional, and national burden and trends analysis of gallbladder and biliary tract cancer from 1990 to 2019 and predictions to 2030: a systematic analysis for the Global Burden of Disease Study 2019
by: Jiao Su, et al.
Published: (2024-04-01)

Wee1 inhibition by MK1775 potentiates gemcitabine through accumulated replication stress leading to apoptosis in biliary tract cancer
by: Chiao-Ping Chen, et al.
Published: (2023-10-01)

Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review
by: Changhoon Yoo, et al.
Published: (2021-04-01)

Cardiotoxicity caused by gemcitabine
by: Yuri Isaakyan, et al.
Published: (2023-01-01)

Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials
by: Matthew Ledenko, et al.
Published: (2022-08-01)

Endobiliary Radiofrequency Ablation Combined with Gemcitabine and Cisplatin in Patients with Unresectable Extrahepatic Cholangiocarcinoma
by: Tadahisa Inoue, et al.
Published: (2022-03-01)

A case of a congenital umbilicobiliary fistula associated with gallbladder agenesis in a dog
by: Lisa Alexandra Mestrinho, et al.
Published: (2022-05-01)

Effect of Rowachol on the Gallbladder Dysmotility Disorder Based on Gallbladder Ejection Fraction
by: Sang Hoon Lee, et al.
Published: (2023-01-01)

The Effectiveness of the Combination of Arterial Infusion Chemotherapy and Radiotherapy for Biliary Tract Cancer: A Prospective Pilot Study
by: Takuma Goto, et al.
Published: (2023-05-01)

A Novel Gemcitabine-Resistant Gallbladder Cancer Model Provides Insights into Molecular Changes Occurring during Acquired Resistance
by: Luis Vergara-Gómez, et al.
Published: (2023-04-01)

BRAZILIAN CONSENSUS ON INCIDENTAL GALLBLADDER CARCINOMA
by: Felipe Jose F COIMBRA, et al.
Published: (2020-07-01)

Adjuvant chemoradiotherapy in resected gallbladder cancer: A SEER-based study
by: Yong Jiang, et al.
Published: (2023-03-01)

Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of Osteosarcoma
by: Carlos Rodríguez-Nogales, et al.
Published: (2020-07-01)

Angiosarcoma of gallbladder, a literature review
by: Mahsa Salehi, et al.
Published: (2024-01-01)

Neoadjuvant Therapy for Extrahepatic Biliary Tract Cancer: A Propensity Score-Matched Survival Analysis
by: Junya Toyoda, et al.
Published: (2023-04-01)

Gallbladder perforation presenting as a hepatic neoplasm
by: Sangara Narayanan, et al.
Published: (2016-06-01)

Development and investigation of a novel device with gemcitabine for hyperthermic intravesical chemotherapy
by: Li Jing, et al.
Published: (2023-12-01)

Low‐dose gemcitabine plus nab‐paclitaxel versus standard‐dose gemcitabine plus nab‐paclitaxel in elderly patients with metastatic pancreatic cancer: A randomized Phase II trial
by: Ken Kamata, et al.
Published: (2023-09-01)

Comparison of 3 and 4 cycles of neoadjuvant gemcitabine and cisplatin for muscle-invasive bladder cancer: a systematic review and meta-analysis
by: Lanpeng Lu, et al.
Published: (2023-11-01)

Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine—A Randomized Phase II Trial
by: Alice Markussen, et al.
Published: (2020-07-01)

Factors affecting the efficacy of gemcitabine and nab-paclitaxel (paclitaxel + albumin) combination in the Russian patient population: results of a multicenter retrospective study
by: I. A. Pokataev, et al.
Published: (2019-12-01)

Gemcitabine induced pneumonitis: a case report and review of literature
by: Nishanth Thalambedu, et al.
Published: (2020-11-01)